Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kennedy, Oliver"'
Autor:
Kennedy OJ; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK; Division of Cancer Sciences, The University of Manchester, Manchester, M13 9PL, UK. Electronic address: ojk@doctors.org.uk., Ali N; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK., Lee R; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK; Division of Cancer Sciences, The University of Manchester, Manchester, M13 9PL, UK., Monaghan P; Division of Cancer Sciences, The University of Manchester, Manchester, M13 9PL, UK; The Christie Pathology Partnership, Manchester, M20 4BX, UK., Adam S; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK; Division of Cancer Sciences, The University of Manchester, Manchester, M13 9PL, UK., Cooksley T; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK., Lorigan P; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK; Division of Cancer Sciences, The University of Manchester, Manchester, M13 9PL, UK.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113949. Date of Electronic Publication: 2024 Feb 21.
Autor:
Kennedy OJ; University of Manchester, Manchester, United Kingdom; Christie NHS Foundation Trust, Manchester, United Kingdom., Glassee N; EORTC Headquarters, Brussels, Belgium., Kicinski M; EORTC Headquarters, Brussels, Belgium., Blank CU; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Long GV; Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals, Sydney, NSW, Australia., Atkinson VG; Princess Alexandra Hospital, Brisbane, QLD, Australia., Dalle S; Hospices Civils de Lyon Cancer Institute, Lyon, France., Haydon AM; Alfred Hospital, Melbourne, VIC, Australia., Meshcheryakov A; NN Blokhin Cancer Research Center, Moscow, Russian Federation., Khattak A; Fiona Stanley Hospital & Edith Cowan University, Perth, WA, Australia., Carlino MS; Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Larkin J; Royal Marsden Hospital, London, United Kingdom., Puig S; Hospital Clinic de Barcelona, Universitat de Barcelona, IDIBAPS, Spain & Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain., Ascierto PA; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Schadendorf D; University Hospital Essen, Essen, German Cancer Consortium, Partner Site Essen & University Alliance Ruhr Research Center One Health, Essen, Germany., Boers-Sonderen M; Radboud University Medical Center Nijmegen, Nijmegen, Netherlands., Giacomo AMD; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., van den Eertwegh AJM; Amsterdam University Medical Center, location VUMC, Amsterdam, Netherlands., Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France., Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum Campus Minden, Minden, Germany., Jamal R; Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, QC, Canada., van Akkooi ACJ; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia., Gandini S; IEO, European Institute of Oncology IRCCS, Milan, Italy., Buhrer E; EORTC Headquarters, Brussels, Belgium., Suciu S; EORTC Headquarters, Brussels, Belgium., Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France., Eggermont AMM; Princess Máxima Center and University Medical Center Utrecht, Utrecht, Netherlands; Comprehensive Cancer Center Munich, Technical University Munich & Ludwig Maximiliaan University, Munich, Germany., Mandala M; University of Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy., Lorigan P; Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Valpione S; Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Manchester, United Kingdom; Cancer Research UK National Biomarker Centre, Manchester, UK. Electronic address: sara.valpione@nhs.net.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Apr; Vol. 201, pp. 113585. Date of Electronic Publication: 2024 Feb 01.
Autor:
Kennedy OJ; University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom; Christie NHS Foundation Trust, Manchester, Wilmslow Rd, Manchester M20 4BX, United Kingdom. Electronic address: ojk@doctors.org.uk., Kicinski M; EORTC Headquarters, Brussels, Belgium., Valpione S; Division of Immunology, Immunity to Infection and Respiratory Medicine, The University of Manchester, Manchester, United Kingdom., Gandini S; Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy., Suciu S; EORTC Headquarters, Brussels, Belgium., Blank CU; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Long GV; Melanoma Institute Australia, the University of Sydney, and Mater and Royal North Shore Hospitals, Sydney, NSW, Australia., Atkinson VG; Princess Alexandra Hospital, Brisbane, QLD, Australia., Dalle S; Hospices Civils de Lyon Cancer Institute, Lyon, France., Haydon AM; Alfred Hospital, Melbourne, VIC, Australia., Meshcheryakov A; NN Blokhin Cancer Research Center, Moscow, Russian Federation., Khattak A; Fiona Stanley Hospital & Edith Cowan University, Perth, WA, Australia., Carlino MS; Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Larkin J; Royal Marsden Hospital, London, United Kingdom., Puig S; Hospital Clinic de Barcelona, Universitat de Barcelona, IDIBAPS, and Spain &Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain., Ascierto PA; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Schadendorf D; University Hospital Essen, Essen, German Cancer Consortium, Partner Site Essen & University Alliance Ruhr Research Center One Health, Essen, Germany., Boers-Sonderen M; Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., van den Eertwegh AJM; Amsterdam University Medical Center, location VUMC, Amsterdam, the Netherlands., Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France., Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum Campus Minden, Minden, Germany., Jamal R; Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, QC, Canada., van Akkooi ACJ; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia., Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France., Eggermont AMM; Princess Máxima Center and University Medical Center Utrecht, 3584 CS Utrecht, the Netherlands; Comprehensive Cancer Center Munich, Technical University Munich & Ludwig Maximiliaan University, Munich, Germany., Lorigan P; Christie NHS Foundation Trust, Manchester, Wilmslow Rd, Manchester M20 4BX, United Kingdom; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Mandala M; University of Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Aug; Vol. 189, pp. 112900. Date of Electronic Publication: 2023 Apr 29.
Autor:
Kennedy OJ; University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom. Electronic address: ojk@doctors.org.uk., Kicinski M; EORTC Headquarters, Brussels, Belgium., Valpione S; Cancer Research UK Manchester Institute, Manchester and the Christie NHS Foundation Trust, Manchester, United Kingdom., Gandini S; Molecular and Pharmaco-Epidemiology Unit, European Institute of Oncology, IRCCS, Milano, Italy., Suciu S; EORTC Headquarters, Brussels, Belgium., Blank CU; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Long GV; Melanoma Institute Australia, The University of Sydney, And Mater and Royal North Shore Hospitals, Sydney, NSW, Australia., Atkinson VG; Princess Alexandra Hospital, Brisbane, QLD, Australia., Dalle S; Hospices Civils de Lyon Cancer Institute, Lyon, France., Haydon AM; Alfred Hospital, Melbourne, VIC, Australia., Meshcheryakov A; NN Blokhin Cancer Research Center, Moscow, Russian Federation., Khattak A; Fiona Stanley Hospital & Edith Cowan University, Perth, WA, Australia., Carlino MS; Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Larkin J; Royal Marsden Hospital, London, United Kingdom., Puig S; Hospital Clinic de Barcelona, Universitat de Barcelona, Spain &Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain., Ascierto PA; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Schadendorf D; University Hospital Essen, Essen and German Cancer Consortium, Heidelberg, Germany., Koornstra R; Radboud University Medical Center Nijmegen, Nijmegen, Netherlands., Hernandez-Aya L; Washington University School of Medicine, St. Louis, MO, USA., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., van den Eertwegh AJM; Amsterdam University Medical Center, Location VUMC, Amsterdam, Netherlands., Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France., Gutzmer R; Skin Cancer Center, Hannover Medical School, Hannover, and Department of Dermatology, Johannes Wesling Klinikum Minden, Ruhr University Bochum, Minden, Germany., Jamal R; Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montreal, QC, Canada., van Akkooi ACJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France., Eggermont AMM; Comprehensive Cancer Center Munich, Munich, Germany; Princess Máxima Center and University Medical Center Utrecht, Utrecht, Netherlands., Lorigan P; Division of Cancer Sciences, University of Manchester and Christie NHS Foundation Trust, Manchester, United Kingdom., Mandala M; University of Perugia, Santa Maria Misericordia Hospital, Perugia, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Apr; Vol. 165, pp. 97-112. Date of Electronic Publication: 2022 Feb 24.